Sign in

    Angus Kelliher • Barclays PLC

    Angus Kelleher-Ferguson is a Wall Street Analyst at Barclays, focusing on the General sector with coverage of 17 companies across areas including real estate and communication services. His performance metrics include a 2.17-star rating on TipRanks, with success rates around 46-47% and average returns of approximately 3.3% per recommendation, having rated stocks such as BCE Inc., Regency Centers, Kimco Realty, and American Tower. Kelleher-Ferguson began his analyst career prior to his current appointment at Barclays, where he has established a broad company coverage footprint, though detailed previous firm history is not available in public sources. His professional credentials, registrations, or securities licenses are not explicitly noted in accessible public data.

    Angus Kelliher's questions to National Vision Holdings Inc (EYE) leadership

    Angus Kelliher's questions to National Vision Holdings Inc (EYE) leadership • Q1 2025

    Question

    Angus Kelliher, on for Adrian Yih at Barclays, requested early insights from tests of smaller-format America's Best stores and their impact on future store growth. He also asked for feedback from doctors regarding the strategic shift toward managed care customers.

    Answer

    Executive Alex Wilkes shared that the company is testing smaller store prototypes and has engaged a design firm to review the future store footprint, with a working hypothesis that smaller formats are viable. He added that doctors are enthusiastic about the focus on managed care, as these patients are typically more compliant with annual exams, which aligns with optometrists' professional standards for patient care.

    Ask Fintool Equity Research AI

    Angus Kelliher's questions to National Vision Holdings Inc (EYE) leadership • Q1 2025

    Question

    Angus Kelliher, on for Adrian Yih at Barclays PLC, asked for early insights from testing smaller-format America's Best stores and the potential impact on future store growth. He also inquired about the feedback from doctors regarding the strategic shift to target more managed care customers.

    Answer

    CEO Alex Wilkes shared that while they are testing smaller store prototypes and have engaged a design firm to review the store footprint, it is a forward-looking initiative with no immediate impact on 2025 plans. He noted that doctors are very supportive of the managed care focus, as these patients tend to be more compliant with annual exams and have a shorter, more predictable purchase cycle, which aligns well with clinical best practices.

    Ask Fintool Equity Research AI